CIK: 1325710 - Address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham, MA 02451
48 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1131-1-017813
S%wins58455848434550

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/20/24 16:06
2/16/24
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS.d-4115.620-3-2109D
1/18/24 16:15
1/16/24
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-3514.470-2-394D
12/14/23 16:05
12/13/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-4315.370-3-397D
10/31/23 16:11
10/30/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-2812.020-2-391D
10/4/23 16:05
10/2/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-3712.680-3-385D
6/21/23 16:05
6/16/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-2414.400-2-288D
2/17/23 16:07
2/16/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS.d-1515.100-1-188D
1/19/23 16:05
1/17/23
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-5121.240-2-373D
10/5/22 16:05
10/3/22
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-4818.730-3-374D
6/21/22 16:37
6/16/22
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-1910.750-2-277D
2/18/22 17:01
2/16/22
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-99.050-1-177D
10/6/21 16:00
10/4/21
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS-8833.170-3-546D
2/18/21 19:00
2/16/21
DCPHDeciphera Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSherman Matthew LMAOEVP,ChieS.d-648.8700048D
4/4/18 16:39
4/3/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS-17738.430-5-677D
1/4/18 19:02
1/3/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS-19842.710-5-582D
9/14/17 17:02
9/12/17
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS-70738.410-18-1887D
7/7/17 16:55
7/5/17
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.d-51232.000-16-13105D
1/6/17 17:12
1/4/17
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS-5527.4612-2-2105D-29-27-20-25-27-6-1610-8-1
7/6/16 17:47
7/1/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.d-90334.7413-26-2482D-28-2710-4-8-6-6-22-13-27
4/8/16 16:02
4/6/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.dm-83232.0011-26-2294D-14-1130-153033228-31-6816-17
10/16/15 16:41
10/15/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS-14023.288-6-6100M10-17-28-26-14-11034446382922
9/18/15 16:15
9/16/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS-6633.247-2-2106M37-18102623122-7-19-3324-30-4
8/19/15 16:38
8/18/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.d-21831.135-7-1442M4-20-7799-5-8-131315-15-3
7/21/15 16:10
7/20/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.d-19532.465-6-1244M22-22-307915-70-2055
6/19/15 16:41
6/18/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.d-22131.545-7-1445M-8-16-257-622315124110
5/19/15 16:26
5/18/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.d-22732.377-7-1346M2-7-15-5511212-6-28-3
4/21/15 16:44
4/20/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.d-16833.528-5-1048M-1316-19-18-12-1-10-6-2-3-28-13
3/20/15 17:12
3/18/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.d-24741.189-6-1437M7661313443-2-13-19-24-16-39
3/6/15 16:06
3/4/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOEVP,ChieS.d-28540.758-7-1638M-216116795414-15-21-27-29
1/22/15 16:17
1/20/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-29141.6411-7-1443M-244634-94-5-5123-13-17-12
12/19/14 17:20
12/18/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-20140.1616-5-1141M491667194-77-1405-1713
12/12/14 16:37
12/10/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-21743.4615-5-1140M48226182117-3-9-3-3-2-261
12/12/14 16:37
5/19/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.a-6331.5115-2-1314D48226182117-3-9-3-3-2-261
11/18/14 17:20
11/18/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-17233.768-5-1142M6851613-7-3-2-391922-17
11/14/14 16:03
11/12/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-16333.118-5-1043M81101814329-121314-26
10/20/14 16:22
10/20/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS-14329.108-5-1044M31-20716-3-40018144316-13
10/9/14 16:59
10/8/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-15029.506-5-949M30-2007232-320174017-16
9/19/14 16:18
9/18/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS-12725.484-5-950M-37-28-14-100-431819637147
9/4/14 16:12
9/3/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-12925.824-5-855M-51-14-8-12-7-6-3-117376013
8/19/14 16:24
8/18/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS-7429.625-3-456M-35-62220-30-1017347
8/15/14 16:05
8/14/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-22329.795-8-1159M-32-5-10710-1-12-1413275
7/22/14 16:34
7/18/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS-6626.228-3-642M-45-26-16-20-11-347785515
7/11/14 17:32
7/9/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-21728.9911-8-1445M-26-201-11-11-3-6-16-1036-1
6/20/14 16:59
6/18/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS-8634.4211-3-546M24-127162400-22-2914-11
6/13/14 16:53
6/11/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-24933.2311-8-1349M14-25010146-31-16-2328-7
5/30/14 16:35
5/28/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS.d-23230.9710-8-1350M42-36-20-6-4-11216-52113
5/21/14 18:52
5/19/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS-7931.5412-3-552M61-28-12-8016515-31212
4/24/14 17:07
4/22/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagSherman Matthew LMAOSVP,ChieS-17935.8312-5-952M49-41-31-13-9-1327-2-12-87

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact